Table 2. Diuretics used on the First Day of Trial Drug Administration.
Item/category | Tolvaptan (N = 46) | Placebo (N = 45) | p value |
Use of diuretic | 0.6216 | ||
Loop diuretic alone | 21 (45.7%) | 18 (40.0%) | |
Loop + Spironolactone | 19 (41.3%) | 24 (53.3%) | |
Loop + Spironolactone + Thiazide | 3 (6.5%) | 2 (4.4%) | |
Loop + Thiazide | 3 (6.5%) | 1 (2.2%) | |
Dose of loop diuretic* | 0.3585 | ||
< 40 mg/day | 6 (13.0%) | 9 (20.0%) | |
40 mg/day-80 mg/day | 36 (78.3%) | 29 (64.4%) | |
≥ 80 mg/day | 4 (8.7%) | 7 (15.6%) |
* Flurosemide oral form equivalence.